BioLight Life Financials
| BOLT Stock | ILS 665.10 14.90 2.19% |
BioLight |
Understanding current and past BioLight Life Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BioLight Life's financial statements are interrelated, with each one affecting the others. For example, an increase in BioLight Life's assets may result in an increase in income on the income statement.
Please note, the presentation of BioLight Life's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BioLight Life's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of BioLight Life's management manipulating its earnings.
BioLight Life Stock Summary
BioLight Life competes with Discount Investment, Ormat Technologies, Harel Insurance, Adgar Investments, and Hiron Trade. BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions comprising glaucoma, dry eye syndrome, and age-related macular degeneration. BioLight Life Sciences Ltd. was founded in 2005 and is based in Tel Aviv, Israel. BIOLIGHT LIFE operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.| Foreign Associate | USA |
| Instrument | Israel Stock View All |
| Exchange | Tel Aviv Stock Exchange |
| ISIN | IL0010952237 |
| Business Address | Atidim Park Tel |
| Sector | Life Sciences Tools & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | bio-light.co.il |
| Phone | 972 7 327 53400 |
| Currency | ILS - Israeli Shekel |
You should never invest in BioLight Life without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of BioLight Stock, because this is throwing your money away. Analyzing the key information contained in BioLight Life's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
BioLight Life Key Financial Ratios
BioLight Life's financial ratios allow both analysts and investors to convert raw data from BioLight Life's financial statements into concise, actionable information that can be used to evaluate the performance of BioLight Life over time and compare it to other companies across industries.| Return On Equity | -0.0911 | |||
| Return On Asset | -0.0925 | |||
| Target Price | 12.0 | |||
| Beta | 0.53 | |||
| Z Score | -4.2 |
BioLight Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioLight Life's current stock value. Our valuation model uses many indicators to compare BioLight Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioLight Life competition to find correlations between indicators driving BioLight Life's intrinsic value. More Info.BioLight Life Sciences is number one stock in return on equity category among its peers. It is rated second in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value BioLight Life by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioLight Life's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.BioLight Life Sciences Systematic Risk
BioLight Life's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. BioLight Life volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on BioLight Life Sciences correlated with the market. If Beta is less than 0 BioLight Life generally moves in the opposite direction as compared to the market. If BioLight Life Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BioLight Life Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BioLight Life is generally in the same direction as the market. If Beta > 1 BioLight Life moves generally in the same direction as, but more than the movement of the benchmark.
BioLight Life March 25, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of BioLight Life help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BioLight Life Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioLight Life Sciences based on widely used predictive technical indicators. In general, we focus on analyzing BioLight Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioLight Life's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.23 | |||
| Information Ratio | 0.0572 | |||
| Maximum Drawdown | 14.65 | |||
| Value At Risk | (4.10) | |||
| Potential Upside | 6.93 |
Complementary Tools for BioLight Stock analysis
When running BioLight Life's price analysis, check to measure BioLight Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLight Life is operating at the current time. Most of BioLight Life's value examination focuses on studying past and present price action to predict the probability of BioLight Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLight Life's price. Additionally, you may evaluate how the addition of BioLight Life to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |